Unilife to Present at the Lazard 9th Annual Healthcare Conference in New York City on November 13th
YORK, Pa., Nov. 12, 2012 /PRNewswire/ — Unilife Corporation (“Unilife” or “Company”) (NASDAQ: UNIS, ASX: UNS), today announced that it will be presenting at the Lazard 9(th) Annual Healthcare Conference in New York City. Alan Shortall, Chief Executive Officer of Unilife, is scheduled to present at 2:30 p.m. EST on Tuesday, November 13, 2012.
The conference presentation will be broadcast over the Internet as a “live” listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm. An archive of the event will also be available for those unable to listen live.
About Unilife Corporation
Unilife Corporation (NASDAQ:UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of advanced drug delivery systems. Unilife collaborates with pharmaceutical and biotechnology companies seeking innovative, differentiated devices that can enable or enhance the delivery of injectable drugs and vaccines supplied in either a liquid stable or lyophilized form. The Unifill syringe, the world’s first and only prefilled syringe with fully integrated safety features, sits at the leading edge of this diversified portfolio. In addition to prefilled syringes with automatic, user-controlled needle retraction, Unilife has other proprietary technology platforms including drug reconstitution delivery systems, auto-injectors, bolus injectors, infusion pump systems and targeted delivery systems for organ delivery. Unilife’s global headquarters and state-of-the-art manufacturing facilities are located in York, PA. For more information on Unilife, please visit www.unilife.com
This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management’s beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in “Item 1A. Risk Factors” and elsewhere in our Annual Report on Form 10-K and those described from time to time in other reports which we file with the Securities and Exchange Commission.
Investor Contacts (US): Analyst Enquiries Investor Contacts (Australia) Todd Fromer / Garth Russell Lynn Pieper Jeff Carter KCSA Strategic Communications Westwicke Partners Unilife Corporation P: + 1 212-896-1215 / 212-896-1250 P: + 1 415-202-5678 P: + 61 2 8346 6500
SOURCE Unilife Corporation